Sentiment & Themes Emerging From JPM 2024
LifeSciVC
JANUARY 16, 2024
These are incredible forecasts and CAGRs, which if we assume directionally correct, rely not only on steady growth for approved therapies but also a substantial success rate of, and continued investment in, the development pipeline. Small molecule GLP1s?
Let's personalize your content